Nicotinyl alcohol tartrate (BioDeep_00000824093)
代谢物信息卡片
Nicotinyl alcohol D-tartrate
化学式: C10H13NO7 (259.0692)
中文名称: 烟醇酒石酸盐
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1=CC(=CN=C1)CO.C(C(C(=O)O)O)(C(=O)O)O
InChI: InChI=1S/C6H7NO.C4H6O6/c8-5-6-2-1-3-7-4-6
描述信息
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
同义名列表
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Sabina Grabner, Barbara Modec, Nataša Bukovec, Peter Bukovec, Maja Čemažar, Simona Kranjc, Gregor Serša, Janez Sčančar. Cytotoxic trans-platinum(II) complex with 3-hydroxymethylpyridine: Synthesis, X-ray structure and biological activity evaluation.
Journal of inorganic biochemistry.
2016 08; 161(?):40-51. doi:
10.1016/j.jinorgbio.2016.04.031. [PMID: 27189143] - Philips O Akinwole, Emilie Lefevre, Martha J Powell, Robert H Findlay. Unique odd-chain polyenoic phospholipid fatty acids present in chytrid fungi.
Lipids.
2014 Sep; 49(9):933-42. doi:
10.1007/s11745-014-3934-3. [PMID: 25119485] - Matteo de Rosa, Andrea Pennati, Vittorio Pandini, Enrico Monzani, Giuliana Zanetti, Alessandro Aliverti. Enzymatic oxidation of NADP+ to its 4-oxo derivative is a side-reaction displayed only by the adrenodoxin reductase type of ferredoxin-NADP+ reductases.
The FEBS journal.
2007 Aug; 274(15):3998-4007. doi:
10.1111/j.1742-4658.2007.05934.x. [PMID: 17635583] - D Cui, P J Harvison. Determination of the site of glucuronidation in an N-(3,5-dichlorophenyl)succinimide metabolite by electrospray ionization tandem mass spectrometry following derivatization to picolinyl esters.
Rapid communications in mass spectrometry : RCM.
2000; 14(21):1985-90. doi:
10.1002/1097-0231(20001115)14:21<1985::aid-rcm122>3.0.co;2-f. [PMID: 11085408] - P P Rop, F Grimaldi, C Oddoze, A Viala. Determination of nicotine and its main metabolites in urine by high-performance liquid chromatography.
Journal of chromatography.
1993 Feb; 612(2):302-9. doi:
10.1016/0378-4347(93)80177-6. [PMID: 8468389] - H Kleiber, R Munger, D Jallut, L Tappy, C Felley, A Golay, P Frascarolo, E Jéquier, J P Felber. Interaction of lipid and carbohydrate metabolism after infusions of lipids or of lipid lowering agents: lack of a direct relationship between free fatty acid concentrations and glucose disposal.
Diabete & metabolisme.
1992 Mar; 18(2):84-90. doi:
NULL. [PMID: 1511757] - C P Felley, H Kleiber, G D van Melle, P Frascarolo, E Jéquier, J P Felber. Resistance to insulin mediated glucose disposal in obese subjects: respective effect of lipid metabolism and glycemia.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
1992 Mar; 16(3):185-91. doi:
". [PMID: 1317827] - N Zöllner. Effects of nicotinic acid, nicotinamide, and pyridylcarbinol in pharmacological dosages on lipid metabolism in humans.
International journal for vitamin and nutrition research. Supplement = Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Supplement.
1989; 30(?):114-9. doi:
". [PMID: 2529321] - H Arola. The strip test for hypolactasia also works without ethanol.
Scandinavian journal of gastroenterology.
1988 Sep; 23(7):851-5. doi:
10.3109/00365528809090772. [PMID: 3227302] - M Meylan, C Henny, E Temler, E Jéquier, J P Felber. Metabolic factors in the insulin resistance in human obesity.
Metabolism: clinical and experimental.
1987 Mar; 36(3):256-61. doi:
10.1016/0026-0495(87)90185-5. [PMID: 3547014] - L Jacobsson. [Experimental hyperlipoproteinemia and arteriosclerosis in minipigs--effect of various drugs].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.
1986 Jul; 41(14):387-91. doi:
NULL. [PMID: 3532591] - M Cohen. Antihyperlipidemic properties of beta-pyridylcarbinol. A review of preclinical studies.
Life sciences.
1985 Nov; 37(21):1949-61. doi:
10.1016/0024-3205(85)90026-8. [PMID: 3906330] - C Keller, S Hailer, T Demant, G Wolfram, N Zöllner. Effect of plasma exchange with and without concomitant drug treatment on lipids and lipoproteins in patients with familial hypercholesterolemia confirmed by tissue culture.
Atherosclerosis.
1985 Nov; 57(2-3):225-34. doi:
10.1016/0021-9150(85)90036-x. [PMID: 4084356] - W Reuter. [Modification of pathologic fatty acid patterns in old age by combined clofibrinic and nicotinic acid treatment].
Zeitschrift fur Alternsforschung.
1983 Sep; 38(5):383-8. doi:
. [PMID: 6659567] - L Zanaboni, D Sommariva, D Bonfiglioli, A Fasoli. [Effects of nicotinic alcohol therapy on serum lipoproteins in patients with hyperbetalipoproteinemia].
La Clinica terapeutica.
1983 Jun; 105(6):487-91. doi:
NULL. [PMID: 6617111] - A Dembińska-Kieć, R Korbut, K Bierón, E Kostka-Trabka, R J Gryglewski. beta-Pyridylcarbinol (Ronicol) releases a prostacyclin-like substance into arterial blood of patients with arteriosclerosis obliterans.
Pharmacological research communications.
1983 Apr; 15(4):377-85. doi:
10.1016/s0031-6989(83)80047-2. [PMID: 6346344] - W Reuter. [Clinico-experimental long-term study on the combined effect of clofibrin and nicotinic acid on abnormal fatty acid patterns in lipid metabolism disorders in the aged].
Zeitschrift fur Alternsforschung.
1983 Jan; 38(1):57-62. doi:
. [PMID: 6405546] - L Jacobsson, L Lundholm. Experimental atherosclerosis in hypercholesterolemic mini-pigs. Regression of cholesterol ester accumulation in aorta and coronary arteries after treatment with clofibrate, beta-pyridylcarbinol or a normo-lipidemic diet.
Atherosclerosis.
1982 Nov; 45(2):129-48. doi:
10.1016/0021-9150(82)90134-4. [PMID: 6760875] - H Kahles, G Hellige, D H Hunneman, V A Mezger, H J Bretschneider. Influence of myocardial substrate utilization on the oxygen consumption of the heart.
Clinical cardiology.
1982 Apr; 5(4):286-93. doi:
10.1002/clc.4960050404. [PMID: 7083652] - W Sziegoleit, M Lohse, H Riedel, W Förster. [Effect of allopurinol on adrenergically induced changes in serum lipid levels, heart rate and blood pressure in normal and ischemic rabbits (author's transl)].
Arzneimittel-Forschung.
1982; 32(3):218-21. doi:
NULL. [PMID: 7200779] - U Butturini. Vitamins E and A in vascular diseases.
Acta vitaminologica et enzymologica.
1982; 4(1-2):15-9. doi:
NULL. [PMID: 6751049] - F F Morpeth, F M Dickinson. Kinetic studies of the mechanism of pig kidney aldehyde reductase.
The Biochemical journal.
1981 Feb; 193(2):485-92. doi:
10.1042/bj1930485. [PMID: 7030310] - B Henke, D Westerlund. Hydrophobic chromatography and bioanalysis of some polar pyridine derivatives used as antilipolytic agents.
Journal of chromatography.
1980 Jan; 187(1):189-98. doi:
10.1016/s0021-9673(00)87885-1. [PMID: 7358815] - H Kala, R Danz, H Bekemeier, H Moldenhauer. [In vivo testing of a 3-hydroxymethylpyridine hydrogen tartrate matrix tablet. Part 2: Comparison between the in vivo drug release from the matrix form and that from Radecol-tablets (author's transl)].
Die Pharmazie.
1980; 35(4):216-21. doi:
NULL. [PMID: 7403243] - J G Wechsler, V Hutt, H U Klör, H Ditschuneit. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Artery.
1980; 8(6):519-29. doi:
". [PMID: 7259531] - P Schwandt, P Weisweiler, G Neureuther. The effect of beta-pyridylcarbinol on lipoprotein lipids in primary type IIa hyperlipoproteinemia.
Atherosclerosis.
1979 Sep; 34(1):35-9. doi:
10.1016/0021-9150(79)90103-5. [PMID: 227427] - C A Dujovne, D L Azarnoff, P Pentikainen, C V Manion, A Hurwitz. A comparative trial of clofibrate and nicotinyl alcohol tartrate in hyperlipoproteinemic patients.
The American journal of the medical sciences.
1979 May; 277(3):255-61. doi:
10.1097/00000441-197905000-00002. [PMID: 222145] - M R Parwaresch, H Haacke, C Mäder. Efficacy of hypolipidemic treatment in inhibition of experimental atherosclerosis: the effect of nicotinic acid and related compounds.
Atherosclerosis.
1978 Dec; 31(4):395-401. doi:
10.1016/0021-9150(78)90134-x. [PMID: 215172] - J Schneider, R Schubotz, E v Manteuffel, H Kaffarnik. [Drug treatment of hypercholesterolemia. Experience with a combination of dextrothyroxine and betapyridylcarbinol (author's transel)].
Medizinische Klinik.
1978 Jun; 73(23):874-7. doi:
". [PMID: 661731] - R Mordasini, A Müller, G Klose, G Middelhoff, J Augustin, W Haase, H Greten. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
MMW, Munchener medizinische Wochenschrift.
1978 Apr; 120(15):525-8. doi:
. [PMID: 206826] - R Mordasini, E Schlumpf, P C Nobile, G Brun del Re, G Riva. [Treatment with high-dose beta-pyridylcarbinol: results in patients with hypercholesterinemia].
Schweizerische medizinische Wochenschrift.
1978 Apr; 108(14):533-8. doi:
NULL. [PMID: 635510] - G P Fodor. [Liapten--a new lipid depressor. Clinical experience in lipid metabolism disorders].
ZFA. Zeitschrift fur Allgemeinmedizin.
1978 Jan; 54(1):49-55. doi:
". [PMID: 622856] - L Graham, R Mulcahy, N Hickey. Comparison of the lipid-lowering effect of clofibrate, and of clofibrate plus beta-pyridylcarbinol.
Atherosclerosis.
1977 Aug; 27(4):487-92. doi:
10.1016/0021-9150(77)90166-6. [PMID: 884003] - W Reuter. [Effects of various modes of therapy on the fatty acid spectrum in hyperlipoproteinemia].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.
1977 Jul; 32(13):203-5. doi:
NULL. [PMID: 930182] - L A Carlson, G Olsson, D Ballantyne. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Atherosclerosis.
1977 Apr; 26(4):603-9. doi:
10.1016/0021-9150(77)90127-7. [PMID: 193526] - N Zöllner, C Keller, G Wolfram. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
Medizinische Klinik.
1976 Apr; 71(18):768-74. doi:
NULL. [PMID: 818496] - G Bondesson, C Hedbom, O Magnusson, N E Stjernström. Potential hypolipidemic agents. XIII. Synthesis and plasma lipid-lowering properties of some acetals derived from 3-pyridylmethanol or nicotinaldehyde.
Acta pharmaceutica Suecica.
1976; 13(1):1-8. doi:
. [PMID: 1258658] - H Moldenhauer, H Kala, S Erbe. [The manufacture and testing of matrix tablets with a silicone resin base].
Die Pharmazie.
1975 Nov; 30(11):720-4. doi:
". [PMID: 1219772] - G Leopold, Z Simane, K D Stoll, J Breuer. [Comparative clinico-pharmacological studies on the lipid lowering effect of EMO 100 and clofibrate].
Die Medizinische Welt.
1975 Aug; 6(35):1542-4. doi:
". [PMID: 1177741] - G M Brown, S H Kirpalani. A critical review of the clinical relevance of growth hormone and its measurement in the nuclear medicine laboratory.
Seminars in nuclear medicine.
1975 Jul; 5(3):273-85. doi:
10.1016/s0001-2998(75)80015-8. [PMID: 807973] - A Ilebekk, N E Miller, O D Mjös. Effects of nicotine and inhalation of cigarette smoke on total body oxygen consumption in dogs.
Scandinavian journal of clinical and laboratory investigation.
1975 Jan; 35(1):67-72. doi:
10.1080/00365517509068007. [PMID: 1129594]
